reference/18577178

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18577178

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Comparative Study\|Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	430
issn	0277-0008 1875-9114
issueIdentifier	4
pageRange	424-430
publicationName	Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
startingPage	424
bibliographicCitation	Crémieux AC, Katlama C, Gillotin C, Demarles D, Yuen GJ, Raffi F; AZl10002 Study Group. A comparison of the steady-state pharmacokinetics and safety of abacavir, lamivudine, and zidovudine taken as a triple combination tablet and as abacavir plus a lamivudine-zidovudine double combination tablet by HIV-1-infected adults. Pharmacotherapy. 2001 Apr;21(4):424–30. doi: 10.1592/phco.21.5.424.34497. PMID: 11310515.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_27e41f6bbe075221fd99f1355d6b778c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_370907b6c6882b4ede8b4e49c4e3e450 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7df77de5f2713787c2e72af03a33801c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7ea719cfe61f8a1f3758afdf74faeca2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_770b5a449e3c2829aa4f493299c6fdcb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5f12b337033bc2194e3c0f7caffb98a4
date	200104
identifier	https://pubmed.ncbi.nlm.nih.gov/11310515 https://doi.org/10.1592/phco.21.5.424.34497
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/6511 https://portal.issn.org/resource/ISSN/1875-9114 https://portal.issn.org/resource/ISSN/0277-0008
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	A Comparison of the Steady‐State Pharmacokinetics and Safety of Abacavir, Lamivudine, and Zidovudine Taken as a Triple Combination Tablet and as Abacavir plus a Lamivudine‐Zidovudine Double Combination Tablet by HIV‐1‐Infected Adults
discusses	http://id.nlm.nih.gov/mesh/M0028682 http://id.nlm.nih.gov/mesh/M0006823 http://id.nlm.nih.gov/mesh/M0277557 http://id.nlm.nih.gov/mesh/M0020993 http://id.nlm.nih.gov/mesh/M0028255 http://id.nlm.nih.gov/mesh/M0023387 http://id.nlm.nih.gov/mesh/M0023377
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D015215Q000493 http://id.nlm.nih.gov/mesh/D019259Q000494 http://id.nlm.nih.gov/mesh/D018894Q000493 http://id.nlm.nih.gov/mesh/D015658Q000378 http://id.nlm.nih.gov/mesh/D015497 http://id.nlm.nih.gov/mesh/D015224Q000493
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D019259Q000008 http://id.nlm.nih.gov/mesh/D015658Q000188 http://id.nlm.nih.gov/mesh/D018894Q000008 http://id.nlm.nih.gov/mesh/D015215Q000097 http://id.nlm.nih.gov/mesh/D018592 http://id.nlm.nih.gov/mesh/D019540 http://id.nlm.nih.gov/mesh/D004359 http://id.nlm.nih.gov/mesh/D019259Q000097 http://id.nlm.nih.gov/mesh/D006207 http://id.nlm.nih.gov/mesh/D008657 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D015224Q000097 http://id.nlm.nih.gov/mesh/D015224Q000008 http://id.nlm.nih.gov/mesh/D013607 http://id.nlm.nih.gov/mesh/D018894Q000097 http://id.nlm.nih.gov/mesh/D015658Q000097 http://id.nlm.nih.gov/mesh/D004338 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D015215Q000008
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9765 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60825 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID35370 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441300

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128324017 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128575040

Total number of triples: 64.